Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

Marines, Sailors with PHIBRON 11, 31st MEU receive COVID-19 vaccine

Image of Military health personnel giving the COVID-19 Vaccine to military personnel. Navy Hospital Corpsman 1st Class Javier Flores injects a COVID-19 vaccination to Navy Retail Specialist Seaman Jordan Davis aboard amphibious transport dock ship USS New Orleans. New Orleans, part of the America Expeditionary Strike Group, along with the 31st Marine Expeditionary Unit, is operating in the U.S. 7th Fleet area of responsibility (U.S. Navy photo by Petty Officer 2nd Class Kelby Sanders).

In a critical move for readiness, resiliency and safety, ships of Amphibious Squadron (PHIBRON) 11 received their first dose of the Moderna COVID-19 vaccine last weekend in Okinawa, Japan.

The amphibious transport dock USS New Orleans, along with the amphibious dock landing ships USS Germantown and USS Ashland, in cooperation with U.S. Naval Hospital Okinawa and the embarked 31st Marine Expeditionary Unit, rolled up their sleeves for their first dose of the vaccine.

“As the premier crisis response force in the Indo-Pacific, we have to be ready to respond to the region’s needs at a moment’s notice,” said Navy Capt. Richard LeBron, PHIBRON 11 commodore. “The better protected we are against the coronavirus, the greater assurance I can give our fleet commanders that our ships, Sailors and Marines are without a doubt always here and always ready to fight and deliver when called upon.

“Doing our part to help sink COVID is a huge step for these three ships as they continue to operate throughout the AOR, execute complex and challenging missions, and interact with our allies and partners,” said LeBron.

Vaccination for service members is voluntary, as vaccines are currently authorized for emergency use. Aboard New Orleans, the vast majority of the crew chose to receive the shot.

“The New Orleans crew has shown exceptional resilience in facing COVID-19 over the past year,” said Navy Capt. Brian Schrum, the ship’s commanding officer. “This vaccine will keep our Sailors safe, ready, and confident in our ability to operate forward and overcome any challenges we may encounter.”

Germantown, which recently celebrated the 35th anniversary of the ship’s commissioning, also saw the majority of the crew elect to get the vaccine.

“Following a concerted educational campaign led by our medical team, most of the crew chose to receive the vaccine,” said Navy Cmdr. Cullen Greenfield, Germantown’s commanding officer. “The pandemic has brought many trials, but the Germantown and her crew are resilient, flexible, and creative in meeting those challenges – we expect the vaccine will improve our ability to remain a ready force, stay healthy and operational, and sink COVID.”

According to the Center for Disease Control and Prevention, those receiving the Moderna vaccine should receive the second dose 28 days after the first dose.

“Once a Sailor or Marine is fully vaccinated with both their first and second dose of the Moderna vaccine, they should expect over ninety-four percent efficacy in preventing disease from COVID-19, which will virtually eliminate the risk of severe disease or death during an outbreak at sea,” said Navy Cmdr. Hamilton Tilley, Expeditionary Strike Group 7’s task force surgeon. “Receiving just the first vaccine dose gives significant protection and is the first step in not only protecting themselves but their family as well as fellow Sailors and Marines.”

Amphibious Squadron 11, the Navy’s only forward-deployed amphibious squadron, along with embarked Marines from the 31st Marine Expeditionary Unit, is operating in the U.S. 7th Fleet area of responsibility to enhance interoperability with allies and partners, and serve as a ready response force to defend peace and stability in the Indo-Pacific region.

You also may be interested in...

Policy
Feb 27, 2023

DOD Immunization Program

Establishes policy, assigns responsibilities, and provides procedures to establish a uniform DoD immunization program, in accordance with the authority in DoDD 6200.04 and DoD Instruction (DoDI) 1010.10.

  • Identification #: DODI 6205.02
  • Type: Instructions
Policy
Aug 18, 2022

DHA Policy Memo 22 006

.PDF | 156.56 KB

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

  • Identification #: 22-006
  • Type: Memorandums
Policy
Mar 25, 2021

TAB A MEO COVID19 Medical Coding Policy

.PDF | 161.81 KB

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Type: Memorandums
Policy
Mar 25, 2021

DHA COVID19 Medical Coding PolicyV5 1v

.PDF | 436.92 KB

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Type: Memorandums
Policy
Dec 31, 2020

Providing DoD COVID 19 Vaccines DoD Contractors and Select Foreign Nationals

.PDF | 129.54 KB

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

  • Identification #: N/A
  • Type: Memorandums
Policy
Dec 17, 2020

Guidance for COVID 19 Laboratory Pre Testing Questionnaire

.PDF | 574.09 KB

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

  • Identification #: N/A
  • Type: Memorandums
Policy
Dec 7, 2020

Coronavirus Disease 2019 Vaccine Guidance

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

  • Identification #: N/A
  • Type: Memorandums
Policy
Nov 3, 2020

DHA AI 3020 01

.PDF | 846.31 KB

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

  • Identification #: 3020.01
  • Type: Administrative Instructions
Policy
Aug 21, 2020

DHA PI 6025 34

.PDF | 280.55 KB

Implements instructions, assigns responsibilities, and prescribes procedures for the DOD Northern Hemisphere (NH) and Southern Hemisphere (SH) Seasonal influenza vaccination program.

  • Identification #: 6025.34
  • Type: DHA Procedural Instruction
Policy
May 13, 2020

DHA Policy Memo 20 003

.PDF | 354.70 KB

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum ...

  • Identification #: 20-003
  • Type: Memorandums
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery